share_log

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Benzinga ·  Nov 13, 2024 05:08

Gainers

  • LogicMark (NASDAQ:LGMK) stock rose 61.6% to $0.21 during Tuesday's pre-market session. The company's market cap stands at $2.5 million. As per the news, the Q3 earnings report came out today.
  • CERo Therapeutics Hldgs (NASDAQ:CERO) shares increased by 46.12% to $0.29. The market value of their outstanding shares is at $43.0 million.
  • Nevro (NYSE:NVRO) shares increased by 28.75% to $6.85. The market value of their outstanding shares is at $255.3 million. As per the press release, Q3 earnings came out yesterday.
  • CareCloud (NASDAQ:CCLDP) shares rose 28.17% to $15.97.
  • Taysha Gene Therapies (NASDAQ:TSHA) shares rose 27.56% to $2.08. The company's market cap stands at $426.1 million.
  • CareCloud (NASDAQ:CCLD) shares moved upwards by 22.6% to $3.2. The market value of their outstanding shares is at $51.8 million. As per the press release, Q3 earnings came out today.

Losers

  • Heron Therapeutics (NASDAQ:HRTX) stock decreased by 40.2% to $1.1 during Tuesday's pre-market session. The market value of their outstanding shares is at $166.8 million. As per the press release, Q3 earnings came out today.
  • Neurogene (NASDAQ:NGNE) stock decreased by 31.36% to $49.1. The company's market cap stands at $728.0 million.
  • Neuronetics (NASDAQ:STIM) shares declined by 27.28% to $0.8. The market value of their outstanding shares is at $24.2 million. The company's, Q3 earnings came out today.
  • Rockwell Medical (NASDAQ:RMTI) shares decreased by 25.81% to $3.45. The market value of their outstanding shares is at $107.0 million. The company's, Q3 earnings came out today.
  • Syndax Pharmaceuticals (NASDAQ:SNDX) stock fell 25.3% to $16.27. The market value of their outstanding shares is at $1.3 billion.
  • Quantum-Si (NASDAQ:QSI) shares declined by 18.4% to $0.82. The market value of their outstanding shares is at $116.1 million. As per the press release, Q3 earnings came out today.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment